Worsening of the vitiligo following the second dose of the BNT162B2 mRNA COVID-19 vaccine

Dermatol Ther. 2022 Mar;35(3):e15280. doi: 10.1111/dth.15280. Epub 2021 Dec 28.

Authors

Gokhan Okan¹, Pervin Vural²

Affiliations

¹ Memorial Bahcelievler Hospital, Istanbul, Turkey.
² Department of Biochemistry, Istanbul University, Istanbul, Turkey.

PMID: 34931408
DOI: 10.1111/dth.15280

No abstract available

Publication types

Letter

MeSH terms

BNT162 Vaccine
COVID-19 Vaccines / adverse effects
COVID-19* / prevention & control
Humans
RNA, Messenger
SARS-CoV-2
Vitiligo*

Substances

COVID-19 Vaccines
RNA, Messenger
BNT162 Vaccine